Last reviewed · How we verify

NCT05510882

Effects of Different Treatment Modalities for Obstructive Sleep Apnea on Temporomandibular Joint

Completed NA Last updated 11 April 2023
What this trial tests

NA trial testing different treatment modalities for OSA in Obstructive Sleep Apnea in 39 participants. Completed in 5 August 2022.

Timeline
1 July 2022
Primary endpoint
1 August 2022
5 August 2022

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment39
Start date1 July 2022
Primary completion1 August 2022
Estimated completion5 August 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study aims to evaluate the subjective symptoms, clinical and radiographic signs of temporomandibular disorders related to the use of CPAP, MAD and physical therapy in the treatment of patients with obstructive sleep apnea.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of different treatments for obstructive sleep apnea on temporomandibular joint: a randomized clinical trial.
    Attia AAMM, Awad SS, Mansour M, Baz H, et al · · 2024 · cited 3× · PMID 39129005 · DOI 10.1186/s12903-024-04623-w

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05510882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing